ロード中...
Current Progress in CAR-T Cell Therapy for Solid Tumors
Cancer immunotherapy by chimeric antigen receptor-modified T (CAR-T) cells has shown exhilarative clinical efficacy for hematological malignancies. Recently two CAR-T cell based therapeutics, Kymriah (Tisagenlecleucel) and Yescarta (Axicabtagene ciloleucel) approved by US FDA (US Food and Drug Admin...
保存先:
| 出版年: | Int J Biol Sci |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6854376/ https://ncbi.nlm.nih.gov/pubmed/31754328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.34213 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|